ST.27-legal status data

The legal status information displayed below is based on WIPO Standard ST.27 and of a purely informative nature. Binding information on the status of the IP right is only available in DPMAregister (Show details).

DE file number: 60 2016 066 270.1, EP file number: 16 46 1511.4 (Designation/title: ORALE PHARMAZEUTISCHE FORMULIERUNG VON MONTELUKAST UND LEVOCETIRIZIN UND VERFAHREN ZU DEREN HERSTELLUNG)

↩ Details

Tabular representation
Current state: Not active, Current state: Termination likely/termination

Key event history
No. Key Event Code Key Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q10 Document published Sep 27, 2017Sep 27, 2017 Filing
2 Q10 Document published Nov 9, 2017Nov 9, 2017Nov 9, 2017 Filing
3 Q10 Document published Nov 17, 2021Nov 17, 2021 Examination
4 Q10 Document published Dec 9, 2021Dec 9, 2021Dec 9, 2021 Examination
5 F10 IP right granted Aug 18, 2022Aug 18, 2022Nov 10, 2022 Grant
6 H10 IP right ceased Oct 1, 2024Oct 1, 2024Jan 2, 2025 Termination likely/termination
Detailed event history
No. Detailed Event Code Detailed Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q12 Application published Sep 27, 2017Sep 27, 2017 Filing
2 Q10 Document published Nov 9, 2017Nov 9, 2017Nov 9, 2017 Filing
3 P22 Classification modified May 12, 2021May 12, 2021 Filing
4 Q10 Document published Nov 17, 2021Nov 17, 2021 Examination
5 Q10 Document published Dec 9, 2021Dec 9, 2021Dec 9, 2021 Examination
6 F10 IP right granted Aug 18, 2022Aug 18, 2022Nov 10, 2022 Grant
7 H13 IP right lapsed Oct 1, 2024Oct 1, 2024Jan 2, 2025 Termination likely/termination

Graphical representation

Below you will see a simplified graphical representation of the legal status information, which is based on WIPO Standard ST.27 using the "Overall Patent/SPC Prosecution Model" defined therein.

Graphical representation of the ST.27 legal status data